Company: LCTX
Filing Date: 2025-01-27
Form Type: 8-K
Source: 0000950170-25-009227
Chunk: 1

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-01-27
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01 Regulation FD Disclosure.

On January 27, 2025, we issued a press release announcing the closing of the offering described in Item 8.01 of this report, a copy of which is furnished as Exhibit 99.1 hereto.

The information in this Item 7.01 and in the press release furnished as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), and is not incorporated by reference into any of our filings under the Securities Act or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing.

Item 8.01 Other Events.